アステラス製薬は、2025年米国血液学会(ASH)年次総会において、FLT3遺伝子変異陽性急性骨髄性白血病(AML)の進行におけるXOSPATA™(ギプリチニブ)に関する新たなデータを発表します – プレスリリース
アステラス製薬は、2025年に開催される米国血液学会(ASH)年次総会において、FLT3遺伝子変異陽性の急性骨髄性白血病(AML)疾患スペクトラムにおけるXOSPATA™(ギゲチニブ)に関する新たなデータを発表する予定です。
该文章暂未提取到完整正文,已从资讯列表和商品关联资讯中自动隐藏。你可以返回文章列表继续浏览其他内容。
Products Mentioned in This Article
These products were automatically matched from the article title, summary, and full content.
Frequently Asked Questions
Which products are related to this article?
The system matched these relevant products from the article content: Lucius Quizartinib – Buy Online、Lucius Anagrelide – Buy Online、Lucius Tazemetostat – Buy online、Lucius Acalabrutinib – Buy Online.
How can I view the medicines discussed in this article?
Use the related product cards below the article to review available specifications, prices, product information, and reviews.
Does this article replace advice from a doctor or pharmacist?
No. This content is for general information and health education only. Follow the prescription and individual guidance provided by qualified healthcare professionals.